查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2060204

神經復健設備市場分析與預測（至2035年）：按類型、產品、服務、技術、組件、應用、設備、最終用戶和功能分類

Neurorehabilitation Devices Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Device, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球神經復健設備市場預計將從2025年的31億美元成長到2035年的70億美元，年複合成長率（CAGR）為8.4%。該市場正經歷顯著的銷售成長，主要受神經系統疾病負擔加重和復健需求不斷成長的推動。光是在美國，每年就有約79.5萬例新患者，持續推高了對急性後期神經復健設備和治療方法的需求。在全球範圍內，神經系統疾病影響約10億人，其中相當一部分人需要復健支持以改善運動和認知功能。目前，超過60%的神經復健患者使用復健輔助設備，例如機器人外骨骼、穿戴式感測器和腦機介面系統。在臨床實踐中，全球數千家復健中心每年使用神經復健設備進行數百萬次治療，反映出治療方法迅速普及。中風、帕金森氏症和脊髓損傷的發生率不斷上升，進一步擴大了這些設備在世界各地醫院和居家醫療機構中的使用。

神經復健設備市場依類型細分，包括神經刺激設備、神經機器人系統、腦機介面、穿戴式裝置、非侵入式裝置和侵入式裝置。其中，神經刺激設備是主要細分市場之一，這主要得益於其在恢復中風和帕金森氏症等神經系統疾病患者的運動和認知功能方面的廣泛應用。穿戴式裝置也因其便攜性、易用性以及居家復健需求的不斷成長而迅速普及。同時，腦機介面（BCI）和神經機器人系統是成長最快的先進細分市場，這得益於對人工智慧整合、精準復健和高度個人化神經治療解決方案日益成長的需求。

市場區隔
種類 神經刺激裝置、神經機器人系統、腦機介面、穿戴式裝置、非侵入式裝置、侵入式裝置、其他
產品 義肢、外骨骼、神經回饋系統、認知訓練設備、虛擬實境設備、機器人系統、其他
服務 復健治療、諮商服務、訓練及教育、維護服務、其他
技術 人工智慧、機器學習、虛擬實境（VR）、擴增實境（AR）、物聯網、雲端運算、其他
組件 感測器、執行器、控制器、軟體、其他
用途 中風、腦外傷、巴金森氏症、腦性麻痹、多發性硬化症、其他
裝置 攜帶式設備、固定式設備、穿戴式裝置、其他
最終用戶 醫院、診所、復健中心、居家醫療、其他
功能 運動功能恢復、認知功能恢復、語言治療、其他

神經復健設備市場依終端使用者細分，包括醫院、診所、復健中心和居家醫療機構。其中，復健中心憑藉其專業的設施和著重利用先進神經復健技術開展長期神經功能復健計畫的能力，佔據了相當大的市場佔有率。醫院也佔據了相當大的佔有率，因為它們能夠提供多學科診療，並整合先進的神經刺激療法和機器人系統。居家醫療機構正迅速成為成長最快的細分市場，這主要得益於人們對遠距復健、患者便利性以及穿戴式神經設備（可在臨床環境之外進行持續治療）的需求不斷成長。診所在治療常見神經系統疾病方面也持續穩定採用此類設備。

區域概覽

北美是神經復健設備市場的主導地區，這得益於其先進的醫療基礎設施、高昂的醫療費用支出以及對創新神經技術的積極應用。該地區中風、帕金森氏症和脊髓損傷等神經系統疾病的高發生率，持續推動對復健解決方案的需求。主要醫療設備製造商的強大影響力、完善的復健中心以及有利的償付機制，進一步促進了市場成長。持續的研發投入，以及對神經機器人、腦機介面和穿戴式復健設備等技術的早期應用，進一步鞏固了該地區的市場主導地位。美國擁有最大的市場佔有率，這得益於其強大的臨床研究網路。

亞太地區是神經復健設備成長最快的市場，其主要促進因素包括人口快速老化、神經系統疾病負擔日益加重以及醫療保健投資不斷成長。中國、印度、日本和韓國等國家日益擴大復健基礎設施並採用先進的神經復健技術。如「健康中國2030」等政府主導的舉措，以及人們對早期復原意識的提高，都在推動市場需求。該地區價格適中的穿戴式裝置、遠距復健平台和居家醫療解決方案也呈現強勁成長動能。私人醫療機構的擴張和醫療旅遊的興起進一步加速了這些設備的普及。

主要趨勢和促進因素

神經系統疾病增加和人口老化：

中風、帕金森氏症、多發性硬化症和脊髓損傷等神經系統疾病的日益普遍是推動神經復健設備市場發展的主要因素。隨著全球人口老化，與老齡化相關的神經病變發病率急劇上升，對先進的復健解決方案產生了持續的需求。僅中風一項就是全球導致長期殘疾的主要原因之一，需要大量的急性後期護理和運動功能恢復支援。日益加重的疾病負擔迫使醫療保健系統導入有效的神經復健技術，以加速功能恢復、增強患者的獨立性並降低與慢性殘疾管理相關的長期醫療保健成本。

將機器人技術和人工智慧應用於神經復健：

神經復健設備市場的關鍵趨勢之一是將機器人技術和人工智慧日益融入復健治療。機器人外骨骼、步態訓練器和人工智慧驅動的治療平台正廣泛用於幫助中風、脊髓損傷和神經系統疾病患者恢復運動功能。這些技術透過持續分析患者表現並即時調整治療強度，提供個人化和適應性的治療方案。這不僅改善了復健效果，也減少了對人工物理治療的依賴。精準醫療和自動化復健解決方案日益成長的需求加速創新，使神經復健在全球臨床和居家醫療環境中更有效率、資料驅動和普及。

目錄

第1章 執行摘要

第2章 市場概覽

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機會
  • 市場限制因素
  • 年複合均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 神經刺激裝置
    • 神經機器人系統
    • 腦機介面
    • 穿戴式裝置
    • 非侵入式設備
    • 侵入性設備
    • 其他
  • 市場規模及預測：依產品分類
    • 神經義肢
    • 外骨骼
    • 神經回饋系統
    • 認知訓練設備
    • VR（虛擬實境）設備
    • 機器人系統
    • 其他
  • 市場規模及預測：依服務分類
    • 復健治療
    • 諮詢服務
    • 培訓和教育
    • 維護服務
    • 其他
  • 市場規模及預測：依技術分類
    • 人工智慧
    • 機器學習
    • 虛擬實境（VR）
    • 擴增實境（AR）
    • 物聯網（IoT）
    • 雲端運算
    • 其他
  • 市場規模及預測：依組件分類
    • 感應器
    • 執行器
    • 控制器
    • 軟體
    • 其他
  • 市場規模及預測：依應用領域分類
    • 中風
    • 創傷性腦損傷
    • 帕金森氏症
    • 腦性麻痹
    • 多發性硬化症
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 醫療機構
    • 復健中心
    • 居家醫療
    • 其他
  • 市場規模及預測：依設備類型分類
    • 攜帶式
    • 固定設備
    • 穿戴式裝置
    • 其他
  • 市場規模及預測：依功能分類
    • 運動功能恢復
    • 認知功能恢復
    • 語言治療
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要公司的策略

第8章 公司簡介

  • Bioness
  • Hocoma
  • Ekso Bionics
  • ReWalk Robotics
  • Neofect
  • Aretech
  • Tyromotion
  • Neuro Rehab VR
  • AlterG
  • Motorika
  • Bionik Laboratories
  • NeuroMetrix
  • Kinestica
  • Reha Technology
  • Myomo
  • G-Therapeutics
  • Rehabtronics
  • Reha-Stim Medtec

第9章 關於Global Insight Services

簡介目錄
Product Code: GIS26792

The global Neurorehabilitation Devices Market is projected to grow from $3.1 billion in 2025 to $7.0 billion by 2035, at a compound annual growth rate (CAGR) of 8.4%. Neurorehabilitation devices market is witnessing strong volume expansion driven by rising neurological disorder burden and rehabilitation demand. Stroke alone affects nearly 795,000 new patients annually in the U.S., creating continuous demand for post-acute neurorehabilitation devices and therapies. Globally, neurological disorders impact around 1 billion people, with a significant share requiring motor and cognitive rehabilitation support. More than 60% of neuro-recovery patients now use assistive rehabilitation devices, including robotic exoskeletons, wearable sensors, and braina"computer interface systems. In clinical practice, thousands of rehabilitation centers worldwide collectively deploy millions of therapy sessions annually using neurorehabilitation equipment, reflecting accelerating procedural adoption. Increasing stroke, Parkinson’s disease, and spinal injury cases are further expanding device utilization volumes across hospitals and home-care settings globally.

The type segment of the neurorehabilitation devices market includes neurostimulation devices, neurorobotic systems, brain-computer interface, wearable devices, non-invasive devices, invasive devices, and others. Among these, neurostimulation devices are the leading subsegment, driven by their wide application in restoring motor and cognitive functions in patients with neurological disorders such as stroke and Parkinson’s disease. Wearable devices are also witnessing strong adoption due to portability, ease of use, and increasing demand for home-based rehabilitation. Meanwhile, brain-computer interface and neurorobotic systems represent the fastest-growing advanced segments, supported by AI integration, precision rehabilitation, and rising demand for highly personalized neurotherapy solutions.

Market Segmentation
TypeNeurostimulation Devices, Neurorobotic Systems, Brain-Computer Interface, Wearable Devices, Non-Invasive Devices, Invasive Devices, Others
ProductNeuroprosthetics, Exoskeletons, Neurofeedback Systems, Cognitive Training Devices, Virtual Reality Devices, Robotic Systems, Others
ServicesRehabilitation Therapy, Consultation Services, Training and Education, Maintenance Services, Others
TechnologyArtificial Intelligence, Machine Learning, Virtual Reality, Augmented Reality, Internet of Things, Cloud Computing, Others
ComponentSensors, Actuators, Controllers, Software, Others
ApplicationStroke, Traumatic Brain Injury, Parkinson's Disease, Cerebral Palsy, Multiple Sclerosis, Others
DevicePortable Devices, Fixed Devices, Wearable Devices, Others
End UserHospitals, Clinics, Rehabilitation Centers, Home Care Settings, Others
FunctionalityMotor Function Recovery, Cognitive Function Recovery, Speech Therapy, Others

The end user segment of the neurorehabilitation devices market includes hospitals, clinics, rehabilitation centers, home care settings, and others. Among these, rehabilitation centers are the leading subsegment, driven by their specialized infrastructure and strong focus on long-term neurological recovery programs using advanced neurorehabilitation technologies. Hospitals also account for a significant share due to the availability of multidisciplinary care and integration of advanced neurostimulation and robotic systems. Home care settings are emerging as the fastest-growing segment, supported by increasing demand for remote rehabilitation, patient convenience, and wearable neurodevices enabling continuous therapy outside clinical environments. Clinics continue to show steady adoption across routine neurological treatments.

Geographical Overview

North America is the leading region in the neurorehabilitation devices market due to its advanced healthcare infrastructure, high healthcare spending, and strong adoption of innovative neurotechnology. The region has a high prevalence of neurological disorders such as stroke, Parkinson’s disease, and spinal cord injuries, which drives sustained demand for rehabilitation solutions. Strong presence of key medical device manufacturers, well-established rehabilitation centers, and favorable reimbursement systems further support market growth. Continuous R&D investments and early adoption of technologies like neurorobotics, brain-computer interfaces, and wearable rehabilitation devices strengthen its dominance. The United States accounts for the largest share, supported by robust clinical research networks.

Asia-Pacific is the fastest-growing region in the neurorehabilitation devices market, driven by rapidly aging populations, rising neurological disease burden, and increasing healthcare investments. Countries such as China, India, Japan, and South Korea are expanding rehabilitation infrastructure and adopting advanced neurotechnologies. Growing awareness of early rehabilitation, coupled with government initiatives like a “Healthy China 2030,” is boosting demand. The region is also witnessing strong growth in affordable wearable devices, tele-rehabilitation platforms, and home-based care solutions. Expanding private healthcare providers and rising medical tourism further accelerate adoption.

Key Trends and Drivers

Rising Neurological Disorders and Aging Population:

The growing prevalence of neurological disorders such as stroke, Parkinson’s disease, multiple sclerosis, and spinal cord injuries is a major driver of the neurorehabilitation devices market. With an aging global population, the incidence of age-related neurological impairments is increasing significantly, creating sustained demand for advanced rehabilitation solutions. Stroke alone remains one of the leading causes of long-term disability worldwide, requiring extensive post-acute care and motor recovery support. This rising disease burden is pushing healthcare systems to adopt effective neurorehabilitation technologies that can improve functional recovery, enhance patient independence, and reduce long-term healthcare costs associated with chronic disability management.

Integration of Robotics and AI in Neurorehabilitation:

A key trend in the neurorehabilitation devices market is the increasing integration of robotics and artificial intelligence into rehabilitation therapies. Robotic exoskeletons, assistive gait trainers, and AI-driven therapy platforms are being widely adopted to enhance motor recovery in patients with stroke, spinal cord injuries, and neurological disorders. These technologies provide personalized, adaptive therapy by continuously analyzing patient performance and adjusting treatment intensity in real time. This improves rehabilitation outcomes and reduces dependence on manual physiotherapy. Growing demand for precision medicine and automated rehabilitation solutions is accelerating innovation, making neurorehabilitation more efficient, data-driven, and accessible across clinical and home-care settings globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Device
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Neurostimulation Devices
    • 4.1.2 Neurorobotic Systems
    • 4.1.3 Brain-Computer Interface
    • 4.1.4 Wearable Devices
    • 4.1.5 Non-Invasive Devices
    • 4.1.6 Invasive Devices
    • 4.1.7 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Neuroprosthetics
    • 4.2.2 Exoskeletons
    • 4.2.3 Neurofeedback Systems
    • 4.2.4 Cognitive Training Devices
    • 4.2.5 Virtual Reality Devices
    • 4.2.6 Robotic Systems
    • 4.2.7 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Rehabilitation Therapy
    • 4.3.2 Consultation Services
    • 4.3.3 Training and Education
    • 4.3.4 Maintenance Services
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Artificial Intelligence
    • 4.4.2 Machine Learning
    • 4.4.3 Virtual Reality
    • 4.4.4 Augmented Reality
    • 4.4.5 Internet of Things
    • 4.4.6 Cloud Computing
    • 4.4.7 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Sensors
    • 4.5.2 Actuators
    • 4.5.3 Controllers
    • 4.5.4 Software
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Stroke
    • 4.6.2 Traumatic Brain Injury
    • 4.6.3 Parkinson's Disease
    • 4.6.4 Cerebral Palsy
    • 4.6.5 Multiple Sclerosis
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Clinics
    • 4.7.3 Rehabilitation Centers
    • 4.7.4 Home Care Settings
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Device (2020-2035)
    • 4.8.1 Portable Devices
    • 4.8.2 Fixed Devices
    • 4.8.3 Wearable Devices
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Motor Function Recovery
    • 4.9.2 Cognitive Function Recovery
    • 4.9.3 Speech Therapy
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Device
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Device
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Device
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Device
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Device
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Device
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Device
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Device
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Device
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Device
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Device
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Device
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Device
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Device
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Device
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Device
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Device
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Device
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Device
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Device
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Device
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Device
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Device
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Device
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bioness
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Hocoma
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Ekso Bionics
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 ReWalk Robotics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Neofect
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aretech
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Tyromotion
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Neuro Rehab VR
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 AlterG
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Motorika
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Bionik Laboratories
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 NeuroMetrix
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Kinestica
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Reha Technology
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Myomo
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 G-Therapeutics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Rehabtronics
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Reha-Stim Medtec
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us